contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


magnasense-and-salignostics-initiate-feasibility-study-project

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Magnasense operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and mainly includes drugs for the treatment of multiple sclerosis. In addition to the main business, associated ancillary services are offered. The business is run in collaboration with other pharmaceutical actors, where the largest presence is found in the Nordic region.

Magnasense

Lund, Sweden and Jerusalem, Israel, 29 August 2024 — Magnasense AB and Salignostics Ltd are pleased to announce the commencement of a feasibility study aimed at exploring potential technology...

<div class="mfn-preamble">Lund, Sweden and Jerusalem, Israel, 29 August 2024 — Magnasense AB and Salignostics Ltd are pleased to announce the commencement of a feasibility study aimed at exploring potential technology development opportunities. This project will leverage Magnasense's innovative magnetic test strip technology in conjunction with Salignostics' advanced sample collection devices.</div><div class="mfn-body">This collaborative project between Magnasense AB and Salignostics Ltd is a first step aiming to investigate combining their respective strengths with a focus on accuracy, efficiency, and user-friendliness of diagnostic tests.Marco Witteveen, CEO of Magnasense AB, commented on the project:"At Magnasense, we are always looking for ways to push the boundaries of diagnostic technology. This project with Salignostics allows us to explore new frontiers and expand the applications of our magnetic test strip technology. We are excited about the potential this feasibility study holds and look forward to the innovative solutions that may arise."Dr. Guy Krief, deputy CEO at Salignostics LTD, added:"This project with Magnasense aligns perfectly with our mission to revolutionize sample collection and diagnostic testing. Combining our expertise in sample collection with Magnasense's magnetic test strip technology opens up potential possibilities for technological advancements. We are eager to see the results of this feasibility study."The feasibility study is set to commence in Q3 2024, with both companies dedicating resources and expertise to ensure full commitment and will be finalized in Q4 2024For additional information, please contact: Marco Witteveen, CEO, Magnasense AB Email: ir@magnasense.com The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.seSalignostics Ltd JBP Minrav building Floor 4 Hadassah Ein Kerem Medical Center Jerusalem, Israel office@salignostics.comAbout Salignostics Ltd Salignostics Ltd is at the forefront of sample collection technology, developing advanced devices that simplify and enhance the process of collecting biological samples. Their solutions are designed to support a wide range of diagnostic applications, contributing to better healthcare outcomes.</div><div class="mfn-footer mfn-about mfn-8c31e8f3e677">About Magnasense AB Magnasense is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, Magnasense was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Magnasense's website www.magnasense.com.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments <a rel="noopener" href="https://storage.mfn.se/17a20799-458c-4084-b352-8823c7b90158/magnasense-and-salignostics-initiate-feasibility-study-project.pdf" class="mfn-generated mfn-primary">Magnasense and Salignostics Initiate Feasibility Study Project</a></div>

Stay up to date with our newsletter